Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

First Wave BioPharma Inc. sell nvestor

First Wave BioPharma Inc.
Start price
€2,895.1
11.01.20 / 50%
Target price
€0.000
25.01.20
Performance (%)
-32.25%
End price
€1,961.5
25.01.20
Summary
This prediction ended on 25.01.20 with a price of €1,961.5. The SELL prediction by nvestor for First Wave BioPharma Inc. performed very well with a performance of -32.25%. nvestor has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
First Wave BioPharma Inc. - - - -
iShares Core DAX® -0.870% -1.700% 10.560% 13.129%
iShares Nasdaq 100 -5.561% -3.604% 34.335% 39.856%
iShares Nikkei 225® -6.138% -7.732% 16.215% 0.044%
iShares S&P 500 -3.141% -2.011% 24.534% 39.859%

According to nvestor what are the pros and cons of First Wave BioPharma Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons
Low dividend yield expected
Bad rating
ROE lower than 10% per year
Sustainability is little important
Higher risks for its business
Below average Marketposition
Little known brand
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
negative Cash Flow expected
Little Investments for future growth
Risky balance sheet
Increased challenges to pay loans and raise capital
Below average Management
Bad culture
Little innovation
Few uniques
Dependend from some customers or products
Growths slower than the competition
high free float
Significant cyclical dependencies
Outdated or very high risk business model

Comments by nvestor for this prediction

In the thread First Wave BioPharma Inc. diskutieren

Sell mit Kursziel 0,0

nvestor 
0
Report Share
11.01.20 Sell -32.25%
Prediction Sell
Perf. (%) -32.25%
Target price 0.000
Change
Ends at 25.01.20

Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.

nvestor 
0
Report Share
25.01.20

Stopped prediction by nvestor for First Wave BioPharma Inc.

sell
First Wave BioPharma Inc.

Start price
Target price
Perf. (%)
€8.22
15.10.22
€0.000
15.10.23
2.13%
29.10.22

Low dividend yield expected
Bad rating
ROE lower than 10% per year
Sustainability is little important
nvestor 
15.10.22 50%
sell
First Wave BioPharma Inc.

Start price
Target price
Perf. (%)
€675.52
18.09.21
€209.79
18.09.22
-25.47%
02.10.21

Low dividend yield expected
Bad rating
ROE lower than 10% per year
Sustainability is little important
nvestor 
18.09.21 50%
sell
First Wave BioPharma Inc.

Start price
Target price
Perf. (%)
€3,293.7
23.01.21
€0.000
23.01.22
-55.41%
26.06.21

Low dividend yield expected
Bad rating
ROE lower than 10% per year
Sustainability is little important
nvestor 
23.01.21 50%